ColoSTEM staining outperforms the standard Oct-4 marker in distinguishing CSCs from non-stem tumor cells and healthy cells, suggesting its effectiveness in predicting tumor aggressiveness and therapeutic response in colon cancer patients. Here, POU5F1 is linked to neoplasm.